Protohypericin

CAS No. 548-03-8

Protohypericin( —— )

Catalog No. M21814 CAS No. 548-03-8

Protohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
1 mL x 10 mM in DMSO 217 In Stock
5MG 188 In Stock
10MG 337 In Stock
25MG 559 In Stock
50MG 779 In Stock
100MG 1051 In Stock
200MG 1414 In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    Protohypericin
  • Note
    Research use only, not for human use.
  • Brief Description
    Protohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum.
  • Description
    Protohypericin is a naturally occurring naphthodianthrone derived from plant Hypericum perforatum. Radioiodinated protohypericin is used in Tumor necrosis targeted radiotherapy.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    548-03-8
  • Formula Weight
    506.46
  • Molecular Formula
    C??H??O?
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 125 mg/mL (246.81 mM)
  • SMILES
    O=C(C1=C(O)C=C(C)C=C1C2=C34)C3=C(O)C=C(O)C4=C5C(O)=CC(O)=C6C(C7=C(O)C=C(C)C=C7C2=C65)=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

1. Baugh SF. Simultaneous determination of protopseudohypericin, pseudohypericin, protohypericin, and hypericin without light exposure. J AOAC Int. 2005 Nov-Dec;88(6):1607-12. 2. Liu X, et al. Tumor necrosis targeted radiotherapy of non-small cell lung cancer using radioiodinated protohypericin in a mouse model. Oncotarget. 2015 Sep 22;6(28):26400-10.
molnova catalog
related products
  • Glycolaldehyde dimer

    Glycoaldehyde Dimer is derivative of glycolaldehyde which is the precursor molecule of various significant compounds including amino acid glycine and in the formose reaction.

  • Bococizumab

    Bococizumab(PF-04950615) is a humanized mAb against PCSK9 and an inhibitor of the synthesis of PCSK9 in the liver that reduces the amount of low-density lipoprotein cholesterol (LDL-C) in the blood.Bococizumab is used to treat hypercholesterolemia.

  • BMS-P5

    BMS-P5 is a specific and orally active Peptidylarginine Deiminase 4 (PAD4) inhibitor.